Barrett Burke Thomas's Form 4 filing
Pulse Biosciences, Inc. (PLSE) · filed Dec 20, 2024
- Accession no.
- 0001437749-24-038145
- Filed
- Dec 20, 2024
- Trade date
- Dec 11, 2024
- Filing delay
- 9 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $871.0K. It was filed 9 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Barrett Burke ThomasCIK 0002023875 | Other: Former President and CEO |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 11, 2024 | Common Stock | SSaleDisposed | −50,000 | $17.42 | −$871,000 | 63,172 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.